Compare Alcon AG (ALC) vs The Coca-Cola Co K (KO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs The Coca-Cola Co K — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while The Coca-Cola Co K trades at $84.05 (market cap $361.62B). The key difference: The Coca-Cola Co K is far larger — about 11.1× Alcon AG's market cap, and The Coca-Cola Co K pays the higher dividend (2.52%). Which is the better fit depends on your goals.
| ALC | KO | |
|---|---|---|
Market Cap | $32.69B | $361.62B |
Sector | Health | Consumer Staples |
52-Week High | $92.22 | $84.14 |
52-Week Low | $62.02 | $65.67 |
Enterprise Value | $36.28B | $391.69B |
Dividend Yield | 0.54% | 2.52% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Coca-Cola (KO) trades at $83.395, up 0.52% on the day, with a bullish technical signal and strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $0.86 exceeding the $0.812 forecast. Revenue grew to $47.94 billion in 2025, with a robust net income margin of 27.8%. Analyst consensus is a Buy with a $88.14 price target, indicating potential upside. Recent news highlights institutional buying and stable demand trends, though regional divergences exist.
The outlook for KO is positive, supported by earnings momentum, a solid dividend history, and institutional confidence. Risks include high valuation multiples, such as a P/E of 26.43, and exposure to macroeconomic pressures in certain regions. The stock's proximity to its 52-week high suggests limited near-term upside, but long-term growth prospects remain intact given its market leadership and consistent profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
